{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:26:28Z","timestamp":1780622788768,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","funder":[{"name":"Association V\u00c3\u00a9sale","award":["FDCD\/079\/22\/cc"],"award-info":[{"award-number":["FDCD\/079\/22\/cc"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Evaluating the presence of class 3, 4, and 5 genetic variants in inherited retinal disease (IRD) genes in patients with retinopathy of unknown origin (RUO).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Multicentric retrospective study of RUO cases diagnosed between January 2012 and February 2022. General and ophthalmologic history, complete ophthalmologic examination, antiretinal antibodies, and IRD gene panel results were analyzed in every patient. Four RUO categories were defined: nonparaneoplastic autoimmune retinopathy, unilateral pigmentary retinopathy, asymmetrical pigmentary retinopathy, and acute zonal occult outer retinopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The authors included 12 patients (9 females) across these four RUO categories. Mean age at inclusion was 45.6 years (20\u201368 years). Seven patients demonstrated class 3 variants in IRD genes. Of these, two also demonstrated class 5 variants in other IRD genes. The remaining five patients had negative panel results. IRD gene panel analysis allowed diagnosis refinement in 1 (8.3%) nonparaneoplastic autoimmune retinopathy patient in the RUO cohort. When considering the nonparaneoplastic autoimmune retinopathy subpopulation only, a higher diagnostic yield of 20% (1\/5 patients) was achieved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Every suspected nonparaneoplastic autoimmune retinopathy patient should benefit from gene panel testing to not overlook undiagnosed IRDs. By contrast, unilateral pigmentary retinopathy, asymmetrical pigmentary retinopathy, and acute zonal occult outer retinopathy subpopulations did not benefit from genetic testing in this study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004155","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T20:00:23Z","timestamp":1715630423000},"page":"1597-1607","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["DIAGNOSTIC YIELD OF AN INHERITED RETINAL DISEASE GENE PANEL IN RETINOPATHY OF UNKNOWN ORIGIN"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-3211","authenticated-orcid":false,"given":"St\u00e9phane","family":"Abramowicz","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Saint-Pierre University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"},{"name":"Department of Ophthalmology, Brugmann University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"},{"name":"Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Meunier","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Saint-Pierre University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Postelmans","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Brugmann University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Caspers","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Saint-Pierre University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Corazza","sequence":"additional","affiliation":[{"name":"Department of Immunology, LHUB-ULB, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"De Bruyne","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium;"},{"name":"Department of Biomolecular Medicine, Ghent University, Ghent, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Van de Sompele","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium;"},{"name":"Department of Biomolecular Medicine, Ghent University, Ghent, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elfride","family":"De Baere","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium;"},{"name":"Department of Biomolecular Medicine, Ghent University, Ghent, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart P.","family":"Leroy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium;"},{"name":"Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium;"},{"name":"Division of Ophthalmology, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Willermain","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Saint-Pierre University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"},{"name":"Department of Ophthalmology, Brugmann University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafina","family":"Draganova","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Saint-Pierre University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"},{"name":"Department of Ophthalmology, Brugmann University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ajo.2016.05.013","article-title":"Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified delphi approach","volume":"168","author":"Fox","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaophthalmol.2014.1683","article-title":"Acute zonal occult outer retinopathy: a classification based on multimodal imaging","volume":"132","author":"Mrejen","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R3-20250605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2018.01.002","article-title":"Progress toward precisely diagnosing autoimmune retinopathy","volume":"188","author":"Sobrin","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajo.2013.09.019","article-title":"Autoimmune retinopathy","volume":"157","author":"Grange","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajo.2004.12.104","article-title":"Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies","volume":"139","author":"Weleber","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-4-5","article-title":"Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy","volume":"4","author":"Adamus","year":"2004","journal-title":"BMC Ophthalmol"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.survophthal.2018.03.002","article-title":"A review of the immunologic findings observed in retinitis pigmentosa","volume":"63","author":"McMurtrey","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0002-9394(98)00446-2","article-title":"Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa","volume":"127","author":"Heckenlively","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2415-14-154","article-title":"Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration","volume":"14","author":"Adamus","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ajo.2016.12.001","article-title":"Prevalence of antiretinal antibodies in acute zonal occult outer retinopathy: a comprehensive review of 25 cases","volume":"176","author":"Qian","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fimmu.2018.00765","article-title":"Are anti-retinal autoantibodies a cause or a consequence of retinal degeneration in autoimmune retinopathies?","volume":"9","author":"Adamus","year":"2018","journal-title":"Front Immunol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00281-008-0114-7","article-title":"Autoimmune retinopathy: a review and summary","volume":"30","author":"Heckenlively","year":"2008","journal-title":"Semin Immunopathol"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"100461","DOI":"10.1016\/j.ajoc.2019.100461","article-title":"Predictive value of genetic testing for inherited retinal diseases in patients with suspected atypical autoimmune retinopathy","volume":"15","author":"Stanwyck","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc Ophthalmol"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","article-title":"A robust model for read count data in exome sequencing experiments and implications for copy number variant calling","volume":"28","author":"Plagnol","year":"2012","journal-title":"Bioinformatics"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet Med"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum Mutat"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/gim.2018.42","article-title":"The ACMG\/AMP reputable source criteria for the interpretation of sequence variants","volume":"20","author":"Biesecker","year":"2018","journal-title":"Genet Med"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.ophtha.2014.02.008","article-title":"Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: from syndromic to nonsyndromic retinal degeneration","volume":"121","author":"Nishiguchi","year":"2014","journal-title":"Ophthalmology"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1111\/aos.13981","article-title":"Unilateral pigmentary retinopathy: a retrospective case series","volume":"97","author":"Errera","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/IAE.0000000000000119","article-title":"Autoimmune retinopathy and antiretinal antibodies: a review","volume":"34","author":"Grewal","year":"2014","journal-title":"Retina"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000338240","article-title":"Autoimmune retinopathy","volume":"228","author":"Braithwaite","year":"2012","journal-title":"Ophthalmologica"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:04:26Z","timestamp":1749143066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004155","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}